Primary amebic meningoencephalitis: a review of Naegleria fowleri and analysis of successfully treated cases

Parasitol Res. 2024 Jan 6;123(1):84. doi: 10.1007/s00436-023-08094-w.

Abstract

Primary amebic meningoencephalitis (PAM) is a necrotizing and hemorrhagic inflammation of the brain and meninges caused by Naegleria fowleri, a free-living thermophilic ameba of freshwater systems. PAM remains a neglected disease that disproportionately affects children in tropical and subtropical climates, with an estimated mortality rate of 95-98%. Due to anthropogenic climate change, the average temperature in the USA has increased by 0.72 to 1.06 °C in the last century, promoting the poleward spread of N. fowleri. PAM is often misdiagnosed as bacterial meningitis or viral encephalitis, which shortens the window for potentially life-saving treatment. Diagnosis relies on the patient's history of freshwater exposure and the physician's high index of suspicion, supported by cerebrospinal fluid studies. While no experimental trials have been conducted to assess the relative efficacy of treatment regimens, anti-amebic therapy with adjunctive neuroprotection is standard treatment in the USA. We performed a literature review and identified five patients from North America between 1962 and 2022 who survived PAM with various degrees of sequelae.

Keywords: Brain-eating ameba; Environmental medicine; Meningoencephalitis; Naegleriasis; Protozoal infections; Waterborne diseases.

Publication types

  • Review

MeSH terms

  • Brain
  • Central Nervous System Protozoal Infections* / diagnosis
  • Central Nervous System Protozoal Infections* / drug therapy
  • Child
  • Climate Change
  • Disease Progression
  • Humans
  • Naegleria fowleri*